Company name:
Eagle Pharmaceuticals Inc
-
IPO SHARE PRICE:$15.00
-
IPO DATE:12 February 2014
-
TICKER:EGRX
-
MAIN STOCK EXCHANGE:NASDAQ
-
CURRENT HQ LOCATION:50 Tice Boulevard Suite 315 Woodcliff Lake NJ 07677
-
FISCAL YEAR END:December 31
-
INCORPORATION JURISDICTION:DE
-
ORGANIZED AS THE FOLLOWING LEGAL TYPE:Corporation
-
Investor Relations Webpage:Coming soon!
-
TAX RATE:USA federal corporate nominal income tax rate is 21%
Short Description
Eagle Pharmaceuticals Inc
We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com
Balance Sheet
(USD in thousand)
40.7%
20.2%
3.2%
Selected Year:
31-Dec
2020
2020
Current Assets
Most valuable part of Current Assets is Cash and Marketable Securities which should be watched carefully; at the same time high and growing level of Accounts Receivables is very dangerous sign
65.6%
40.7% —
Cash and cash equivalents
20.2% —
Accounts Receivable
3.2% —
Inventory
1.5% —
Prepaid expenses and other current assets
Liquidity
|
|
|
|
|
|
|
---|---|---|---|---|---|---|
The most liquid asset, however, most companies don't keep much of it and invest excess cash into marketable securities such as Government bonds - in the US - Treasuries
|
$114,657 | $78,791 | $109,775 | $103,155 | ||
Accounts Receivable | 53,821 | 66,486 | 48,004 | 51,117 | ||
Inventory | 5,118 | 8,304 | 6,566 | 8,075 | ||
Prepaid expenses and other current assets | 15,101 | 10,263 | 15,104 | 3,718 | ||
Total current assets | $188,697 | $163,844 | $179,449 | $166,065 |
6.0%
6.8%
5.1%
15.7%
Selected Year:
31-Dec
2020
2020
Non-Current Assets
Non-current assets characterize company's business: high Property, Plant, and Equipment means that company is in capital-intensive industry which typically is very cyclical (earnings fluctuate a lot); watch out for high level of Goodwill and other non-intangibles which is bad sign as they typically worth very low relative to their value shown on the balance sheet
34.4%
15.7% —
Goodwill
6.8% —
Other assets non-current
6.0% —
Deferred tax assets
5.1% —
Intangible assets
0.8% —
Property and equipment net
|
|
|
|
|
|
|
---|---|---|---|---|---|---|
Property and equipment net | 6,820 | 2,397 | 2,202 | 2,077 | ||
Deferred tax assets | 11,354 | 13,822 | 13,669 | 15,180 | ||
Intangible assets
|
23,322 | 18,103 | 15,583 | 12,917 | ||
Goodwill
|
39,743 | 39,743 | 39,743 | 39,743 | ||
Other assets non-current | - | - | 3,908 | 17,208 | ||
Other non-current assets | 124 | 694 | 3,908 | - | ||
Total non-current assets | 81,363 | 74,759 | 75,105 | 87,125 |
Total assets | $270,060 | $238,603 | $254,554 | $253,190 |
9.4%
3.2%
9.9%
33.4%
120.6%
Selected Year:
31-Dec
2020
2020
Current Liabilities
Current Liabilities represent company's short-term dues to others. The most important part to watch for is short-term debt and accounts payables
15.0%
9.4% —
Accrued expenses and other current liabilities
3.2% —
Current maturities of long-term debt
2.5% —
Accounts payable
|
|
|
|
|
|
|
---|---|---|---|---|---|---|
Accounts payable | $11,981 | $9,917 | $5,462 | $6,268 | ||
Accrued expenses | 15,391 | - | - | - | ||
Accrued expenses and other current liabilities | - | 23,519 | 28,361 | 23,817 | ||
Current portion of deferred revenue | - | - | - | - | ||
Current portion of Contingent consideration | 15,055 | - | - | - | ||
Current maturities of long-term debt | 4,875 | 6,250 | 5,000 | 8,000 | ||
Total current liabilities | $47,302 | $39,686 | $38,823 | $38,085 |
Selected Year:
31-Dec
2020
2020
Non-Current Liabilities
The most critical items are revolving credit facility, term loans, and then notes - any forms of debt; in addition, pay attention to items like pension liabilites and leases- hidden debt
11.5%
9.9% —
Long-term debt
1.6% —
Other non-current liabilities
Selected Year:
31-Dec
2020
2020
Equity
It's residue that is owned by shareholders after satisfying all of the liabilities with all of the assets; the larger the amount, the better the business is
73.5%
120.6% —
Additional paid-in capital
33.4% —
Retained earnings
0.0% —
Common stock
|
|
|
|
|
|
|
---|---|---|---|---|---|---|
Preferred Stock
|
- | - | - | - | ||
Preferred stock and Common stock
|
16 | - | - | - | ||
Common stock | - | 17 | 17 | 17 | ||
Treasury Stock | - | - | (171,861) | - | ||
Treasury Stock at cost | (80,795) | (153,900) | (171,861) | (203,898) | ||
Retained earnings | 26,284 | 58,187 | 72,500 | 84,489 | ||
Accumulated deficit
|
- | - | - | - | ||
Additional paid-in capital
|
233,639 | 256,458 | 278,518 | 305,403 | ||
Total Equity | $179,144 | $160,762 | $179,174 | $186,011 |
Total Liabilities and Equity | $270,060 | $238,603 | $254,554 | $253,190 |